Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization.

One of the recent hot topics in peptide-related chemical biology research is the potential of cell-penetrating peptides (CPPs). Owing to their ability to deliver exogenous molecules into cells easily and effectively, their flexible design that allows transporters to comprise various chemical structures and functions, and their potential in chemical and cell biology studies and clinical applications, CPPs have been attracting enormous interest among researchers in related fields. Consequently, publications on CPPs have increased significantly. Although there are many types of CPPs with different physicochemical properties and applications, arginine-rich CPPs, which include the human immunodeficiency virus type 1 (HIV-1) TAT peptide and oligoarginines, are among the most extensively employed and studied. Previous studies demonstrated the importance of the guanidino group in arginine, which confers flexibility in transporter design. Therefore, in addition to peptides, various transporters rich in guanidino groups, which do not necessarily share specific chemical and three-dimensional structures, have been developed. Typically, cell-penetrating transporters have 6-12 guanidino groups. Since the pKa of the guanidino group in arginine is approximately 12.5, these molecules are highly basic and hydrophilic. Our group is interested in why these cationic molecules can penetrate cells. Understanding their mechanism of action should lead to the rational design of intracellular delivery systems that have high efficacy. Additionally, novel cellular uptake mechanisms may be elucidated during the course of these studies. Therefore, our group is trying to understand the basic aspects underlying the ability of these peptides to penetrate cells. Regarding the delivery of biopharmaceuticals including proteins and nucleic acids, achieving efficient and effective delivery to target organs and cells is one of the biggest challenges. Furthermore, when the target sites of these drug molecules are within cells, effective cell penetration becomes another obstacle. Cells are surrounded by a membrane that separates the inside of the cell from its outside. This barrier function is critical for keeping cellular contents inside cells, and without this, cells cannot function. Therefore, understanding the mechanism of action of CPPs is necessary to overcome these obstacles and will allow us not only to improve CPP-mediated delivery but also to create other types of intracellular delivery systems. In this Account, we summarize the current knowledge on the mechanisms of internalization of arginine-rich CPPs, from the viewpoints of both direct cell-membrane penetration (i.e., physicochemical aspects) and endocytic uptake (i.e., physiological aspects), and discuss the implications of this knowledge. We also discussed loosening of lipid packing as a factor to promote direct cell-membrane penetration.

[1]  S. Schwarze,et al.  In vivo protein transduction: delivery of a biologically active protein into the mouse. , 1999, Science.

[2]  Séverine Brulé,et al.  A syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages and HeLa cell line binds the CXC chemokine stromal cell-derived factor-1 (SDF-1). , 2004, Glycobiology.

[3]  S. Futaki,et al.  Identification of cellular proteins interacting with octaarginine (R8) cell-penetrating peptide by photo-crosslinking. , 2013, Bioorganic & medicinal chemistry letters.

[4]  S. Futaki,et al.  Direct Observation of Anion‐Mediated Translocation of Fluorescent Oligoarginine Carriers into and across Bulk Liquid and Anionic Bilayer Membranes , 2005, Chembiochem : a European journal of chemical biology.

[5]  S. Futaki,et al.  Syndecan-4 Is a Receptor for Clathrin-Mediated Endocytosis of Arginine-Rich Cell-Penetrating Peptides. , 2016, Bioconjugate chemistry.

[6]  A. Prochiantz,et al.  Penetratin story: an overview. , 2011, Methods in molecular biology.

[7]  A. Prochiantz,et al.  Cell-Penetrating Peptides , 2021, Methods in Molecular Biology.

[8]  P. Boisguérin,et al.  Delivery of therapeutic oligonucleotides with cell penetrating peptides☆ , 2015, Advanced Drug Delivery Reviews.

[9]  Ari Helenius,et al.  Virus entry by macropinocytosis , 2009, Nature Cell Biology.

[10]  Jeremy C Simpson,et al.  Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  S. Futaki,et al.  Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  M. Green,et al.  Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. , 1988, Cell.

[13]  A. Otaka,et al.  Development of anti-HIV agents targeting dynamic supramolecular mechanism: entry and fusion inhibitors based on CXCR4/CCR5 antagonists and gp41-C34-remodeling peptides. , 2005, Current HIV research.

[14]  S. Futaki,et al.  Acylation of octaarginine: Implication to the use of intracellular delivery vectors. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Christoph Patsch,et al.  The FASEB Journal Research Communication Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells , 2022 .

[16]  Shiroh Futaki,et al.  Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas). , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[17]  J. R. Vargas,et al.  Fifteen years of cell-penetrating, guanidinium-rich molecular transporters: basic science, research tools, and clinical applications. , 2013, Accounts of chemical research.

[18]  P. Couvreur,et al.  Nanocarriers’ entry into the cell: relevance to drug delivery , 2009, Cellular and Molecular Life Sciences.

[19]  S. Futaki,et al.  Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia cells. , 2007, The Biochemical journal.

[20]  S. Futaki,et al.  Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis. , 2007, Biochemistry.

[21]  Carl O. Pabo,et al.  Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.

[22]  S. Futaki,et al.  Arginine-rich Peptides , 2001, The Journal of Biological Chemistry.

[23]  Priscille Brodin,et al.  A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus* , 1997, The Journal of Biological Chemistry.

[24]  M. Oyama,et al.  Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1 , 2010, Nature.

[25]  S. Futaki,et al.  Possible Existence of Common Internalization Mechanisms among Arginine-rich Peptides* , 2002, The Journal of Biological Chemistry.

[26]  S. Futaki,et al.  Curvature engineering: positive membrane curvature induced by epsin N-terminal peptide boosts internalization of octaarginine. , 2013, ACS chemical biology.

[27]  Shiroh Futaki,et al.  Anionic fullerenes, calixarenes, coronenes, and pyrenes as activators of oligo/polyarginines in model membranes and live cells. , 2005, Journal of the American Chemical Society.

[28]  S. Futaki,et al.  Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. , 2008, Advanced drug delivery reviews.

[29]  R. Kay,et al.  Uses and abuses of macropinocytosis , 2016, Journal of Cell Science.

[30]  J. Rothbard,et al.  Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. , 2004, Journal of the American Chemical Society.

[31]  J Barsoum,et al.  Tat-mediated delivery of heterologous proteins into cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[32]  O. Lambert,et al.  The Homeodomain Derived Peptide Penetratin Induces Curvature of Fluid Membrane Domains , 2008, PloS one.

[33]  I. Alves,et al.  Membrane interaction and perturbation mechanisms induced by two cationic cell penetrating peptides with distinct charge distribution. , 2008, Biochimica et biophysica acta.

[34]  J. Rothbard,et al.  Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation , 2000, Nature Medicine.

[35]  Steven F Dowdy,et al.  Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis , 2004, Nature Medicine.

[36]  S. Futaki,et al.  Low concentration thresholds of plasma membranes for rapid energy-independent translocation of a cell-penetrating peptide. , 2009, The Biochemical journal.

[37]  A. Jones Gateways and tools for drug delivery: endocytic pathways and the cellular dynamics of cell penetrating peptides. , 2008, International journal of pharmaceutics.

[38]  P. Wender,et al.  The design of guanidinium-rich transporters and their internalization mechanisms. , 2008, Advanced drug delivery reviews.

[39]  S. Futaki,et al.  Direct and rapid cytosolic delivery using cell-penetrating peptides mediated by pyrenebutyrate. , 2006, ACS chemical biology.

[40]  L. Chernomordik,et al.  Cell-penetrating peptide induces leaky fusion of liposomes containing late endosome-specific anionic lipid. , 2010, Biophysical journal.

[41]  E. Vivés,et al.  Tat peptide-mediated cellular delivery: back to basics. , 2005, Advanced drug delivery reviews.

[42]  S. Futaki,et al.  CXCR4 stimulates macropinocytosis: implications for cellular uptake of arginine-rich cell-penetrating peptides and HIV. , 2012, Chemistry & biology.

[43]  S. Futaki,et al.  Vectorization of biomacromolecules into cells using extracellular vesicles with enhanced internalization induced by macropinocytosis , 2016, Scientific Reports.

[44]  J. Gallagher,et al.  Receptors for fibroblast growth factors , 1995, Immunology and cell biology.

[45]  S. Dowdy,et al.  Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell , 2015, Expert opinion on drug delivery.

[46]  G. Wong,et al.  HIV TAT forms pores in membranes by inducing saddle-splay curvature: potential role of bidentate hydrogen bonding. , 2008, Angewandte Chemie.

[47]  S. Futaki,et al.  Loosening of Lipid Packing Promotes Oligoarginine Entry into Cells. , 2017, Angewandte Chemie.

[48]  S. Futaki,et al.  Octaarginine- and Octalysine-modified Nanoparticles Have Different Modes of Endosomal Escape* , 2008, Journal of Biological Chemistry.

[49]  Sandra L. Schmid,et al.  Regulated portals of entry into the cell , 2003, Nature.

[50]  Hidekazu Hiroaki,et al.  High-resolution multi-dimensional NMR spectroscopy of proteins in human cells , 2009, Nature.

[51]  S. Futaki,et al.  Effect of the attachment of a penetration accelerating sequence and the influence of hydrophobicity on octaarginine-mediated intracellular delivery. , 2012, Molecular pharmaceutics.

[52]  I. Nakase,et al.  Active macropinocytosis induction by stimulation of epidermal growth factor receptor and oncogenic Ras expression potentiates cellular uptake efficacy of exosomes , 2015, Scientific Reports.

[53]  Pietro De Camilli,et al.  BAR, F-BAR (EFC) and ENTH/ANTH domains in the regulation of membrane-cytosol interfaces and membrane curvature. , 2006, Biochimica et biophysica acta.

[54]  S. Futaki,et al.  Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans. , 2008, Bioconjugate chemistry.

[55]  S. Futaki,et al.  Molecular interplays involved in the cellular uptake of octaarginine on cell surfaces and the importance of syndecan-4 cytoplasmic V domain for the activation of protein kinase Cα. , 2014, Biochemical and biophysical research communications.

[56]  Yeu‐Chun Kim,et al.  Stimuli-Responsive Polypeptides for Biomedical Applications , 2018, Polymers.